Alcista
$6.15
Precio del escenario
$5.520
-0.060 (-1.08%)Al cierre
Banco Santander Brasil SA (Cayman Islands Branch) is a Cayman Islands-based company. The Company operated as a branch of Banco Santander Brasil SA in Brazil which provides commercial banking.
Banco Santander Brasil is not a strong buy right now due to its current price of $5.58 being close to its 52-week low and an RSI of 34.763, indicating potential oversold conditions. The stock has shown a 5-day change of -3.96% and a year-to-date change of -10.14%, reflecting a downward trend. However, the forward P/E ratio of 5.9844 suggests it may be undervalued compared to its earnings potential. The main risk is the downgrade from analysts due to a weak Q2 report, which has raised concerns about credit cycle risks.
HSBC
—
2026-09-15
HSBC
2026-09-15
Precio objetivo
—
UBS
—
2026-08-24
UBS
2026-08-24
Precio objetivo
—
UBS
—
2026-08-23
UBS
2026-08-23
Precio objetivo
—
JPMorgan
$6
2026-07-30
JPMorgan
2026-07-30
Precio objetivo
$6
JPMorgan
$7
2026-07-07
JPMorgan
2026-07-07
Precio objetivo
$7
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Investor Perspectives on Multiple Companies

Mistral AI Secures €3 Billion Funding to Compete with OpenAI

European Banks Recover but Momentum Weakens

General Motors Secures $4.5 Billion Parts Agreement

Santander Brasil (BSBR) Q2 2026 Earnings Call Transcript
Banco Santander Brasil SA (Cayman Islands Branch) is a Cayman Islands-based company. The Company operated as a branch of Banco Santander Brasil SA in Brazil which provides commercial banking. It operates in the Financials sector.
Banco Santander Brasil is not a strong buy right now due to its current price of $5.58 being close to its 52-week low and an RSI of 34.763, indicating potential oversold conditions. The stock has shown a 5-day change of -3.96% and a year-to-date change of -10.14%, reflecting a downward trend. However, the forward P/E ratio of 5.9844 suggests it may be undervalued compared to its earnings potential. The main risk is the downgrade from analysts due to a weak Q2 report, which has raised concerns about credit cycle risks.
6 analysts cover BSBR: 1 rate it Buy, 3 Hold and 2 Sell.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.